|
Confirmed
Speakers
Prof.
Tony Pawson, University of Toronto
“Structural
analysis of pro-oncogenic proteins with SH2 and tyrosine kinase domains”
Dr.
Sandra Jacob, Novartis
“Structural
Biology Contributions to the Discovery of Drugs to
Treat Imatinib-Resistant Chronic Myelogenous Leukemia and
Gastrointestinal
Stromal Tumors”
Dr.
Harren Jhoti, ASTEX Pharmaceuticals
“Fragment-based drug discovery for
Oncology targets”
Prof.
Thomas Helleday, Stockholm
University/ University of Oxford
“DNA replication repair: basic mechanisms
and novel cancer treatments”
Dr.
Sonia Lain, Karolinska Institutet
"Discovery, In Vivo Activity And Mechanism Of Action Of
Small-Molecule P53 Activators”
Prof. Pär Nordlund, Karolinska Institutett
"Structural Biology Of Cancer Pathways”
|